PRCT
NASDAQ HealthcarePROCEPT BioRobotics Corporation - Common Stock
Medical Devices
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
๐ Market Data
| Price | $24.63 |
|---|---|
| Volume | 1,215,588 |
| Market Cap | 1.40B |
| Beta | 0.930 |
| RSI (14-Day) | 54.7 |
| 200-Day MA | $33.31 |
| 50-Day MA | $25.17 |
| 52-Week High | $66.85 |
| 52-Week Low | $19.35 |
| Forward P/E | -28.17 |
| Price / Book | 3.79 |
๐ฏ Investment Strategy Scores
PRCT scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ช Falling Knife (89/100) โ this strategy Contrarian plays (oversold + below moving average).
Lowest fit among scored strategies: ๐ Institutional Whale (31/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find PRCT in your text
Paste any article, transcript, or post โ the tool will extract PRCT and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.